Perfume compositions

Abstract

A compacted perfume composition comprising at least three Performance Markers A1, each of them at a level higher than or equal to their specific Critical Compaction Concentration (CCC), respectively, the total concentration of said Performance Markers being higher than 1% by weight of the compacted perfume composition; at least one Performance Vehicle A2, the total concentration of said Performance Vehicle being higher than 10% by weight of the compacted perfume composition; and at least one Performing Diluent B1, the total concentration of said Performing Diluents being higher than 5% by weight of the compacted perfume composition.

Claims

1. A compacted perfume composition comprising: a) at least three Performance Markers A1, each of them at a level higher than or equal to the concentration given in parentheses, respectively, the total concentration of said Performance Markers A1 being higher than 1% by weight of the compacted perfume composition, wherein the Performance Markers A1 are selected from the group consisting of (2-(1-propoxyethoxy)ethyl)benzene (0.25%); acetophenone (0.6%); 1-(pyrazin-2-yl)ethanone (0.1%); 2,6,10-trimethylundec-9-enal (0.25%); 2-methyldecanal (0.5%); undec-10-enal (0.7%); hexanal (0.55%); heptanal (0.15%); 3,5,5-trimethylhexanal (0.45%); (E)-undec-9-enal (0.75%); 3,8,8,11a-tetramethyldodecahydro-1H-3,5a-epoxynaphtho[2,1-c]oxepine (0.05%); 1,3,4,5,6,7-hexahydro-.beta.,1,1,5,5-pentamethyl-2H-2,4a-methanonaphthalene-8-ethanol (0.15%); 2,5,5-trimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-ol (0.1%); (4aR,5R,7aS,9R)-Octahydro-2,2,5,8,8,9a-hexamethyl-4h-4a,9-methanoazuleno[5,6-d]-1,3-dioxole (0.05%); oct-1-en-3-ol (0.2%); 7-isopentyl-2H-benzo[b][1,4]dioxepin-3(4H)-one (0.005%); 8-(sec-butyl)-5,6,7,8-tetrahydroquinoline, (0.01%); (1R,5S,E)-1,5-dimethylbicyclo[3.2.1]octan-8-one oxime (0.03%); 6-(sec-butyl)quinoline (0.1%); 7-methyl-2H-benzo[b][1,4]dioxepin-3(4H)-one (0.2%); 3-hydroxy-4,5-dimethylfuran-2(5H)-one (0.000075%); 5-isopropyl-2-methylphenol (0.4%); 5-tert-butyl-2-methyl-5-propyl-2H-furan (0.10%); (E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)hepta-1,6-dien-3-one (0.5%); 2-((3,7-dimethyloct-6-en-1-yl)oxy)acetaldehyde (0.2%); 2-(2-mercaptopropan-2-yl)-5-methylcyclohexanone (0.02%); (4S)-4,7,7-trimethyl-6-thiabicyclo[3.2.1]octane (0.3%); 2-(3-phenylpropyl)pyridine (0.015%); 2-hydroxy-3-methylcyclopent-2-enone (0.3%); p-tolyl octanoate (0.15%), 1-methoxy-4-methylbenzene (0.5%); 4-isopropylbenzonitrile (0.05%); 4-isopropylbenzaldehyde (0.2%); (E)-1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one (0.1%); (E)-1-(2,6,6-trimethylcyclohex-3-en-1-yl)but-2-en-1-one (0.3%); decanenitrile (0.3%); (E)-dec-2-enal (0.01%); (E)-dec-4-enal (0.1%); 9-decenal (0.05%); 2-(2-(3,3,5-trimethylcyclohexyl)acetyl)cyclopentanone (0.1%); (E)-dodec-2-enal (0.1%); (E)-4-((3aS,7aS)-hexahydro-1H-4,7-methanoinden-5(6H)-ylidene)butanal (0.15%); ethyl-3 dimethyl-2(5 or 6) pyrazine (0.03%); 8-ethyl-1-oxaspiro[4.5]decan-2-one (0.03%); methyl 2,4-dihydroxy-3,6-dimethylbenzoate (0.65%); (E)-undec-9-enenitrile (0.15%); methyl oct-2-ynoate (0.15%); 1-(3,3-dimethylcyclohex-1-en-1-yl)pent-4-en-1-one (0.2%); 2-methoxyphenol (0.05%); E-hex-2-enal (0.15%); 2-ethyl-4-hydroxy-5-methylfuran-3(2H)-one (0.1%); 2-phenylpropanal (0.25%); 2-isobutyl-3-methoxypyrazine (0.000005%); 2-isobutylquinoline (0.1%); (E)-2-methoxy-4-(prop-1-en-1-yl)phenol (0.7%); 6-isopropylquinoline (0.25%); 5-(sec-butyl)-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane (0.55%); (3E,6E)-2,4,4,7-tetramethylnona-6,8-dien-3-one oxime (0.05%); bicyclo[2.2.2]oct-5-ene-2-carboxaldehyde (0.1%); 2-methoxy-3-methylpyrazine (0.2%); 2-hydroxy-3,4-dimethyl-2-cyclopenten-1-one (0.4%); 4,4,8a-trimethyldecahydronaphthalen-4a-ol (0.025%); 2-ethyl-4-methyl-1,3-thiazole (0.07%); 8-methyl-1-oxaspiro[4.5]decan-2-one (0.15%); methyl non-2-ynoate (0.1%); 10-isopropyl-2,7-dimethyl-1-oxaspiro[4.5]deca-3,6-diene (0.3%); (E)-methyl non-2-enoate (0.45%); 1-(3-methylbenzofuran-2-yl)ethanone (0.15%); (2E,6Z)-nona-2,6-dienal (0.02%); (Z)-non-6-enal (0.045%); 2-methyl-4-propyl-1,3-oxathiane (0.1%); 2-(4-methylcyclohex-3-en-1-yl)propane-2-thiol (0.0000065%); 5-methyl-2(2-methylethyl)-cyclohexanone (0.01%); 2-cyclohexylhepta-1,6-dien-3-one (0.1%); 2-phenyl-ethanal (0.2%); (2E,5E)-5,6,7-trimethylocta-2,5-dien-4-one (0.05%); 6-(sec-butyl)quinoline (0.1%); dec-9-en-1-ol (0.4%); 4-methyl-2-(2-methylprop-1-en-1-yl)tetrahydro-2H-pyran (0.4%); 4-methylene-2-phenyltetrahydro-2H-pyran (0.10%); 2,3,3-trimethyl-2,3-dihydro-1H-inden-1-one (0.1%); 2,6,6-trimethylcyclohexa-1,3-dienecarbaldehyde (0.05%); 4-vinylcyclohex-1-enecarbaldehyde (0.15%); 1-spiro[4.5]dec-7-en-7-yl-4-penten-1-one (0.15%); 2-(p-tolyl)acetaldehyde (0.1%); (E)-3,7-dimethylocta-2,6-diene-1-thiol (0.05%); 4-methylbenzaldehyde (1%); 1-(cyclopropylmethyl)-4-methoxybenzene (0.10%); E-hex-2-enal (0.15%); (E)-tridec-2-enenitrile (0.1%); 3-phenylbutanal (0.5%); 2-ethoxy-4-methylphenol (0.15%); (3E,5Z)-undeca-1,3,5-triene (0.05%); (E)-undec-2-enal (0.1%); (E)-4-isopropyl-1-methyl-2-(prop-1-en-1-yl)benzene (0.25%); (2E,6Z)-nona-2,6-dienenitrile (0.01%); and 2-(2,4-dimethylcyclohexyl)pyridine (0.05%); b) at least one Performance Vehicle A2, the total concentration of said Performance Vehicle A2 being higher than 10% by weight of the compacted perfume composition, wherein the Performance Vehicle A2 is selected from the group consisting of dodecanal; 2-methylundecanal; (Z)-oxacycloheptadec-10-en-2-one; 3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan; 3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan; (E)-1-methoxy-4-(prop-1-en-1-yl)benzene; 4-methoxybenzaldehyde; butyl butanoate; 6-methoxy-2,6-dimethyloctanal; (E)-3,7-dimethylocta-2,6-dienal; (E)-1,1-dimethoxy-3,7-dimethylocta-2,6-diene; (E)-1,1-diethoxy-3,7-dimethylocta-2,6-diene; (Z)-1,1-diethoxy-3,7-dimethylocta-2,6-diene; 3,7-dimethyloct-6-enal; 3,7-dimethyloct-6-enenitrile; 2,4,4,7-tetramethyloct-6-en-3-one; (Z)-3-methylcyclotetradec-5-enone; 2H-chromen-2-one; p-cresol; 8,8-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carbaldehyde; 2,4,6-trimethylcyclohex-3-enecarbaldehyde; allyl 2-(cyclohexyloxy)acetate; (E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-en-1-one; 6-isopropyloctahydronaphthalen-2(1H)-one; 3-methyl-2-pentylcyclopent-2-enone; 1-methoxy-4-propylbenzene; 2-methoxy-4-propylphenol; 4,7-dimethyloct-6-en-3-one; (E)-3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol; 3-(1-ethoxyethoxy)-3,7-dimethylocta-1,6-diene; ethyl butyrate; 2-ethyl-3-hydroxy-4H-pyran-4-one; ethyl 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate; 3-ethoxy-4-hydroxybenzaldehyde; ethyl 2-methylbutanoate; ethyl 2-hydroxybenzoate; 3-(3-isopropylphenyl)butanal; (3aR,6S,7aS)-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl propionate; 3-methyldodecanenitrile; N,2-dimethyl-N-phenylbutanamide; (3aR,6S,7aS)-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl isobutyrate; Geranium essence; 2-(2-hydroxypropan-2-yl)-5-methylcyclohexanol; 3-ethoxy-1,1,5-trimethylcyclohexane; 2-hexylcyclopent-2-enone; (E)-3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one; (3aR,6S,7aS)-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl acetate; 2-hexylcyclopentanone; (1-methyl-2-((1,2,2-trimethylbicyclo[3.1.0]hexan-3-yl)methyl)cyclopropyl)methanol; (Z)-1-(1-ethoxy ethoxy)hex-3-ene; (2E,6Z)-3,7-dimethylnona-2,6-dienenitrile; (Z)-hex-3-en-1-yl methyl carbonate; (E)-methyl 2-(((2,4-dimethylcyclohex-3-en-1-yl)methylene)amino)benzoate; 2-(5-methyl-5-vinyltetrahydrofuran-2-yl)propan-2-ol; ethyl 2-methylpentanoate; 3-methyl-5-phenylpentanal; 2,6-dimethylhept-5-enal; 1-(p-tolyl)ethanone; (E)-1,2-dimethoxy-4-(prop-1-en-1-yl)benzene; methyl 2-hydroxybenzoate; (Z)-3-methylcyclopentadec-5-enone; 2-(2-(4-methylcyclohex-3-en-1-yl)propyl)cyclopentanone; 2-ethyl-N-methyl-N-(m-tolyl)butanamide; Patchouli essence; 5-heptyldihydrofuran-2(3H)-one; 2-cyclohexylidene-2-phenylacetonitrile; 2-cyclohexylidene-2-(o-tolyl)acetonitrile; 3-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)propanal; (3aR,6S,7aS)-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl pivalate; (E)-3,3-dimethyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol; 5-pentyldihydrofuran-2(3H)-one; 2-pentylcyclopentanone; (E)-2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol; 4-(4-hydroxyphenyl)butan-2-one; 2,4-dimethyl-4-phenyltetrahydrofuran; (2R,8aS)-3′,6-dimethyl-3,4,4a,5,8,8a-hexahydro-1H-spiro[1,4-methanonaphthalene-2,2′-oxirane]; 3-isobutyl-1-methylcyclohexanol; methyl 2-((E)-((E)-2-benzylideneheptylidene)amino)benzoate; cyclopentadecanone and hexadecanolide; (E)-5-methylheptan-3-one oxime; (E)-2-((3,5-dimethylhex-3-en-2-yl)oxy)-2-methylpropyl cyclopropanecarboxylate; 1-(2,2,6-trimethylcyclohexyl)hexan-3-ol; 4-methylbenzaldehyde; (E)-4-methyldec-3-en-5-ol; 4-hydroxy-3-methoxybenzaldehyde; (E)-2-ethoxy-5-(prop-1-en-1-yl)phenol; (Z)-cyclohexadec-5-enone; 4-methyl-4-phenylpentan-2-yl acetate; 2-methoxynaphthalene; (4E)-9-hydroxy-5,9-dimethyl-4-decenal; 1-methyl-2-(5-methylhex-4-en-2-yl)cyclopropyl)-methanol; and 3-(4-isobutyl-2-methylphenyl)propanal; and c) at least one Performing Diluent B1, the total concentration of said Performing Diluent B1 being higher than 5% by weight of the compacted perfume composition, wherein the Performing Diluent B1 is selected from the group consisting of 2-(tert-butyl)cyclohexyl acetate; pentyl 2-hydroxybenzoate; propanedioic acid 1-(1-(3,3-dimethylcyclohexyl)ethyl) 3-ethyl ester; benzyl 2-hydroxybenzoate; (1S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one; 3,7-dimethyloct-6-en-1-ol; citrus essence; 3-(4-isopropylphenyl)-2-methylpropanal; cyclohexyl 2-hydroxybenzoate; methyl 1,4-dimethylcyclohexanecarboxylate; 1-oxacycloheptadecan-2-one; 3-methyl-2-pentylcyclopent-2-enone; 2,6-dimethyloct-7-en-2-ol; 2,6-dimethylheptan-2-ol; 2,6-dimethyloct-7-en-2-yl formate; 1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene; 1,4-dioxacycloheptadecane-5,17-dione; (1s,4s)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane; 1-(3,5,5,6,8,8-hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethanone; tetrahydro-4-methyl-2-(2-methylpropyl)-2H-pyran-4-ol; 2-(sec-butyl)cyclohexanone; 4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8-hexahydrocyclopenta[g]isochromene; 1-phenylethyl acetate; 1-(1,2,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone; (E)-3,7-dimethylocta-2,6-dien-1-ol; (E)-oxacyclohexadec-12-en-2-one; methyl 3-oxo-2-pentylcyclopentaneacetate; 2-(1-(3,3-dimethylcyclohexyl)ethoxy)-2-methylpropyl propionate; (2 S)-ethyl 3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; 2-butyl-4,4,6-trimethyl-1,3-dioxane; hexyl 2-hydroxybenzoate; 7-hydroxy-3,7-dimethyloctanal; (E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one; 1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone; (4Z)-hept-4-en-2-yl 2-hydroxybenzoate; 3-(4-(tert-butyl)phenyl)-2-methylpropanal; linal oxide; 3,7-dimethylocta-1,6-dien-3-ol; (4-isopropylcyclohexyl)methanol; 6,6-dimethoxy-2,5,5-trimethylhex-2-ene; 1a,3,3,4,6,6-hexamethyl-1a,2,3,4,5,6,7,7a-octahydronaphtho[2,3-b]oxirene; 1,4-dioxacyclohexadecane-5,16-dione; cyclopentadecanone; 1,7-dioxacycloheptadecan-8-one; (E)-13-methyloxacyclopentadec-10-en-2-one; 2,4-dimethyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-dioxolane; orange essence; 4-(tert-butyl)cyclohexyl acetate; 2-phenylethanol; acetic acid (1-oxopropoxy)-, 1-(3,3-dimethylcyclohexyl)ethyl ester; 1-(3,3-dimethylcyclohexyl)ethyl acetate; (3S)-3,7-Dimethyloct-7-en-1-ol; 2-(1-(3,3-dimethylcyclohexyl)ethoxy)-2-methylpropyl cyclopropanecarboxylate; 3-(4-isobutylphenyl)-2-methylpropanal; (E)-6,10-dimethylundeca-5,9-dien-2-yl acetate; 3,7-dimethyloctan-3-ol; and oxacyclohexadecan-2-one, wherein the perfume composition comprises less than 3% by weight of low odour ingredients having an Odour Value of less than 100, and wherein the compacted perfume composition is adapted for use as a constituent for a compacted consumer product in an amount of between 0.01 to 0.75% by weight of the compacted consumer product.

2. The compacted perfume composition according to claim 1, further comprising at least one perfumery ingredient B2 belonging to none of the groups A1, A2 and B1 and having an Odour Value of 100 or more.

3. The compacted perfume composition according to claim 1, having a floral character.

4. The compacted perfume composition according to claim 1, wherein the compacted perfume composition is encapsulated.

5. A consumer product comprising the compacted perfume composition as defined in claim 1.

6. The consumer product according to claim 5, further comprising at least one solvent selected from water-soluble, water-insoluble and partially water-soluble solvents.

7. The consumer product according to claim 5, further comprising at least one texturing agent or colloid stabilizer, selected from the group consisting of rheology modifiers, thickeners, gel-forming agents, thixotropic agents and dispersing agents.

8. The consumer product according to claim 5, further comprising at least one compound selected from the group consisting of silicones, active cosmetic ingredients, fabric enhancing agents, preservatives, deodorizing agents, solubilized, and water soluble uncomplexed cyclodextrins.

9. The consumer product according to claim 5, further comprising at least one surfactant selected from the group consisting of anionic, cationic, cationogenic, zwitterionic, amphoteric and non-ionic surfactants.

10. A process of constructing compacted perfume compositions comprising the step of admixing: a) at least three Performance Markers A1, each of them at a level higher than or equal to the concentration given in parentheses, respectively, the total concentration of said Performance Markers A1 being higher than 1% by weight of the compacted perfume composition, wherein the Performance Markers A1 are selected from the group consisting of (2-(1-propoxyethoxy)ethyl)benzene (0.25%); acetophenone (0.6%); 1-(pyrazin-2-yl)ethanone (0.1%); 2,6,10-trimethylundec-9-enal (0.25%); 2-methyldecanal (0.5%); undec-10-enal (0.7%); hexanal (0.55%); heptanal (0.15%); 3,5,5-trimethylhexanal (0.45%); (E)-undec-9-enal (0.75%); 3,8,8,11a-tetramethyldodecahydro-1H-3,5a-epoxynaphtho[2,1-c]oxepine (0.05%); 1,3,4,5,6,7-hexahydro-.beta.,1,1,5,5-pentamethyl-2H-2,4a-methanonaphthalene-8-ethanol (0.15%); 2,5,5-trimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-ol (0.1%); (4aR,5R,7a S,9R)-Octahydro-2,2,5,8,8,9a-hexamethyl-4h-4a,9-methanoazuleno[5,6-d]-1,3-dioxole (0.05%); oct-1-en-3-ol (0.2%); 7-isopentyl-2H-benzo[b][1,4]dioxepin-3(4H)-one (0.005%); 8-(sec-butyl)-5,6,7,8-tetrahydroquinoline (0.01%); (1R,5S,E)-1,5-dimethylbicyclo[3.2.1]octan-8-one oxime (0.03%); 6-(sec-butyl)quinoline (0.1%); 7-methyl-2H-benzo[b][1,4]dioxepin-3 (4H)-one (0.2%); 3-hydroxy-4,5-dimethylfuran-2(5H)-one (0.000075%); 5-isopropyl-2-methylphenol (0.4%); 5-tert-butyl-2-methyl-5-propyl-2H-furan (0.10%); (E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)hepta-1,6-dien-3-one (0.5%); 2-((3,7-dimethyloct-6-en-1-yl)oxy)acetaldehyde (0.2%); 2-(2-mercaptopropan-2-yl)-5-methylcyclohexanone (0.02%); (4 S)-4,7,7-trimethyl-6-thiabicyclo[3.2.1]octane (0.3%); 2-(3-phenylpropyl)pyridine (0.015%); 2-hydroxy-3-methylcyclopent-2-enone (0.3%); p-tolyl octanoate (0.15%); 1-methoxy-4-methylbenzene (0.5%); 4-isopropylbenzonitrile (0.05%); 4-isopropylbenzaldehyde (0.2%); (E)-1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one (0.1%); (E)-1-(2,6,6-trimethylcyclohex-3-en-1-yl)but-2-en-1-one (0.3%); decanenitrile (0.3%); (E)-dec-2-enal (0.01%); (E)-dec-4-enal (0.1%); 9-decenal (0.05%); 2-(2-(3,3,5-trimethylcyclohexyl)acetyl)cyclopentanone (0.1%); (E)-dodec-2-enal (0.1%); (E)-4-((3aS,7aS)-hexahydro-1H-4,7-methanoinden-5(6H)-ylidene)butanal (0.15%); ethyl-3 dimethyl-2(5 or 6) pyrazine (0.03%); 8-ethyl-1-oxaspiro[4.5]decan-2-one (0.03%); methyl 2,4-dihydroxy-3,6-dimethylbenzoate (0.65%); (E)-undec-9-enenitrile (0.15%); methyl oct-2-ynoate (0.15%); 1-(3,3-dimethylcyclohex-1-en-1-yl)pent-4-en-1-one (0.2%); 2-methoxyphenol (0.05%); E-hex-2-enal (0.15%); 2-ethyl-4-hydroxy-5-methylfuran-3(2H)-one (0.1%); 2-phenylpropanal (0.25%); 2-isobutyl-3-methoxypyrazine (0.000005%); 2-isobutylquinoline (0.1%); (E)-2-methoxy-4-(prop-1-en-1-yl)phenol (0.7%); 6-isopropylquinoline (0.25%); 5-(sec-butyl)-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane (0.55%); (3E,6E)-2,4,4,7-tetramethylnona-6,8-dien-3-one oxime (0.05%); bicyclo[2.2.2]oct-5-ene-2-carboxaldehyde (0.1%); 2-methoxy-3-methylpyrazine (0.2%); 2-hydroxy-3,4-dimethyl-2-cyclopenten-1-one (0.4%); 4,4,8a-trimethyldecahydronaphthalen-4a-ol (0.025%); 2-ethyl-4-methyl-1,3-thiazole (0.07%); 8-methyl-1-oxaspiro[4.5]decan-2-one (0.15%); methyl non-2-ynoate (0.1%); 10-isopropyl-2,7-dimethyl-1-oxaspiro[4.5]deca-3,6-diene (0.3%); (E)-methyl non-2-enoate (0.45%); 1-(3-methylbenzofuran-2-yl)ethanone (0.15%); (2E,6Z)-nona-2,6-dienal (0.02%); (Z)-non-6-enal (0.045%); 2-methyl-4-propyl-1,3-oxathiane (0.1%); 2-(4-methylcyclohex-3-en-1-yl)propane-2-thiol (0.0000065%); 5-methyl-2(2-methylethyl)-cyclohexanone (0.01%); 2-cyclohexylhepta-1,6-dien-3-one (0.1%); 2-phenyl-ethanal (0.2%); (2E,5E)-5,6,7-trimethylocta-2,5-dien-4-one (0.05%); 6-(sec-butyl)quinoline (0.1%); dec-9-en-1-ol (0.4%); 4-methyl-2-(2-methylprop-1-en-1-yl)tetrahydro-2H-pyran (0.4%); 4-methylene-2-phenyltetrahydro-2H-pyran (0.10%); 2,3,3-trimethyl-2,3-dihydro-1H-inden-1-one (0.1%); 2,6,6-trimethylcyclohexa-1,3-dienecarbaldehyde (0.05%); 4-vinylcyclohex-1-enecarbaldehyde (0.15%); 1-spiro[4.5]dec-7-en-7-yl-4-penten-1-one (0.15%); 2-(p-tolyl)acetaldehyde (0.1%); (E)-3,7-dimethylocta-2,6-diene-1-thiol (0.05%); 4-methylbenzaldehyde (1%); 1-(cyclopropylmethyl)-4-methoxybenzene (0.10%); E-hex-2-enal (0.15%); (E)-tridec-2-enenitrile (0.1%); 3-phenylbutanal (0.5%); 2-ethoxy-4-methylphenol (0.15%); (3E,5Z)-undeca-1,3,5-triene (0.05%); (E)-undec-2-enal (0.1%); (E)-4-isopropyl-1-methyl-2-(prop-1-en-1-yl)benzene (0.25%); (2E,6Z)-nona-2,6-dienenitrile (0.01%); 2-(2,4-dimethylcyclohexyl)pyridine (0.05%); b) at least one Performance Vehicle A2, the total concentration of said Performance Vehicles A2 being higher than 10% by weight of the compacted perfume composition, wherein the Performance Vehicles A2 are selected from the group consisting of dodecanal; 2-methylundecanal; (Z)-oxacycloheptadec-10-en-2-one; 3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan; 3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan; (E)-1-methoxy-4-(prop-1-en-1-yl)benzene; 4-methoxybenzaldehyde; butyl butanoate; 6-methoxy-2,6-dimethyloctanal; (E)-3,7-dimethylocta-2,6-dienal; (E)-1,1-dimethoxy-3,7-dimethylocta-2,6-diene; (E)-1,1-diethoxy-3,7-dimethylocta-2,6-diene; (Z)-1,1-diethoxy-3,7-dimethylocta-2,6-diene; 3,7-dimethyloct-6-enal; 3,7-dimethyloct-6-enenitrile; 2,4,4,7-tetramethyloct-6-en-3-one; (Z)-3-methylcyclotetradec-5-enone; 2H-chromen-2-one; p-cresol; 8,8-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carbaldehyde; I2,4,6-trimethylcyclohex-3-enecarbaldehyde; allyl 2-(cyclohexyloxy)acetate; (E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-en-1-one; 6-isopropyloctahydronaphthalen-2 (1H)-one; 3-methyl-2-pentylcyclopent-2-enone; 1-methoxy-4-propylbenzene; 2-methoxy-4-propylphenol; 4,7-dimethyloct-6-en-3-one; (E)-3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol; 3-(1-ethoxyethoxy)-3,7-dimethylocta-1,6-diene; ethyl butyrate; 2-ethyl-3-hydroxy-4H-pyran-4-one; ethyl 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate; 3-ethoxy-4-hydroxybenzaldehyde; ethyl 2-methylbutanoate; ethyl 2-hydroxybenzoate; 3-(3-isopropylphenyl)butanal; (3aR,6S,7aS)-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl propionate; 3-methyldodecanenitrile; N,2-dimethyl-N-phenylbutanamide; (3aR,6S,7aS)-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl isobutyrate; geranium essence; 2-(2-hydroxypropan-2-yl)-5-methylcyclohexanol; 3-ethoxy-1,1,5-trimethylcyclohexane; 2-hexylcyclopent-2-enone; (E)-3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one; (3aR,6S,7aS)-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl acetate; 2-hexylcyclopentanone; (1-methyl-2-((1,2,2-trimethylbicyclo[3.1.0]hexan-3-yl)methyl)cyclopropyl)methanol; (Z)-1-(1-ethoxyethoxy)hex-3-ene; (2E,6Z)-3,7-dimethylnona-2,6-dienenitrile; (Z)-hex-3-en-1-yl methyl carbonate; (E)-methyl 2-(((2,4-dimethylcyclohex-3-en-1-yl)methylene)amino)benzoate; 2-(5-methyl-5-vinyltetrahydrofuran-2-yl)propan-2-ol; ethyl 2-methylpentanoate; 3-methyl-5-phenylpentanal; 2,6-dimethylhept-5-enal; 1-(p-tolyl)ethanone; (E)-1,2-dimethoxy-4-(prop-1-en-1-yl)benzene; methyl 2-hydroxybenzoate; (Z)-3-methylcyclopentadec-5-enone; 2-(2-(4-methylcyclohex-3-en-1-yl)propyl)cyclopentanone; 2-ethyl-N-methyl-N-(m-tolyl)butanamide; patchouli essence; 5-heptyldihydrofuran-2(3H)-one; 2-cyclohexylidene-2-phenylacetonitrile; 2-cyclohexylidene-2-(o-tolyl)acetonitrile; 3-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)propanal; (3aR,6S,7aS)-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl pivalate; (E)-3,3-dimethyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol; 5-pentyldihydrofuran-2(3H)-one; 2-pentylcyclopentanone; (E)-2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol; 4-(4-hydroxyphenyl)butan-2-one; 2,4-dimethyl-4-phenyltetrahydrofuran; (2R,8aS)-3′,6-dimethyl-3,4,4a,5,8,8a-hexahydro-1H-spiro[1,4-methanonaphthalene-2,2′-oxirane]; 3-isobutyl-1-methylcyclohexanol; methyl 2-((E)-((E)-2-benzylideneheptylidene)amino)benzoate; cyclopentadecanone and hexadecanolide; (E)-5-methylheptan-3-one oxime; (E)-2-((3,5-dimethylhex-3-en-2-yl)oxy)-2-methylpropyl cyclopropanecarboxylate; 1-(2,2,6-trimethylcyclohexyl)hexan-3-ol; 4-methylbenzaldehyde; (E)-4-methyldec-3-en-5-ol; 4-hydroxy-3-methoxybenzaldehyde; (E)-2-ethoxy-5-(prop-1-en-1-yl)phenol; (Z)-cyclohexadec-5-enone; 4-methyl-4-phenylpentan-2-yl acetate; 2-methoxynaphthalene; (4E)-9-hydroxy-5,9-dimethyl-4-decenal; 1-methyl-2-(5-methylhex-4-en-2-yl)cyclopropyl)-methanol; and 3-(4-isobutyl-2-methylphenyl)propanal; and c) at least one Performing Diluent B1, the total concentration of said Performing Diluents B1 being higher than 5% by weight of the compacted perfume composition, wherein the Performing Diluent B1 are selected from the group consisting of 2-(tert-butyl)cyclohexyl acetate; pentyl 2-hydroxybenzoate; propanedioic acid 1-(1-(3,3-dimethylcyclohexyl)ethyl) 3-ethyl ester; benzyl 2-hydroxybenzoate; (1 S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one; 3,7-dimethyloct-6-en-1-ol; citrus essence; 3-(4-isopropylphenyl)-2-methylpropanal; cyclohexyl 2-hydroxybenzoate; methyl 1,4-dimethylcyclohexanecarboxylate; 1-oxacycloheptadecan-2-one; 3-methyl-2-pentylcyclopent-2-enone; 2,6-dimethyloct-7-en-2-ol; 2,6-dimethylheptan-2-ol; 2,6-dimethyloct-7-en-2-yl formate; 1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene; 1,4-dioxacycloheptadecane-5,17-dione; (1s,4s)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane; 1-(3,5,5,6,8,8-hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethanone; tetrahydro-4-methyl-2-(2-methylpropyl)-2H-pyran-4-ol; 2-(sec-butyl)cyclohexanone; 4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8-hexahydrocyclopenta[g]isochromene; 1-phenylethyl acetate; 1-(1,2,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone; (E)-3,7-dimethylocta-2,6-dien-1-ol; (E)-oxacyclohexadec-12-en-2-one; methyl 3-oxo-2-pentylcyclopentaneacetate; 2-(1-(3,3-dimethylcyclohexyl)ethoxy)-2-methylpropyl propionate; (2 S)-ethyl 3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; 2-butyl-4,4,6-trimethyl-1,3-dioxane; hexyl 2-hydroxybenzoate; 7-hydroxy-3,7-dimethyloctanal; (E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one; 1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone; (4Z)-hept-4-en-2-yl 2-hydroxybenzoate; 3-(4-(tert-butyl)phenyl)-2-methylpropanal; linal oxide; 3,7-dimethylocta-1,6-dien-3-ol; (4-isopropylcyclohexyl)methanol; 6,6-dimethoxy-2,5,5-trimethylhex-2-ene; 1a,3,3,4,6,6-hexamethyl-1a,2,3,4,5,6,7,7a-octahydronaphtho[2,3-b]oxirene; 1,4-dioxacyclohexadecane-5,16-dione; cyclopentadecanone; 1,7-dioxacycloheptadecan-8-one; (E)-13-methyloxacyclopentadec-10-en-2-one; 2,4-dimethyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-dioxolane; orange essence; 4-(tert-butyl)cyclohexyl acetate; 2-phenylethanol; acetic acid (1-oxopropoxy)-, 1-(3,3-dimethylcyclohexyl)ethyl ester; 1-(3,3-dimethylcyclohexyl)ethyl acetate; (3S)-3,7-Dimethyl oct-7-en-1-ol; 2-(1-(3,3-dimethylcyclohexyl)ethoxy)-2-methylpropyl cyclopropanecarboxylate; 3-(4-isobutylphenyl)-2-methylpropanal; (E)-6,10-dimethylundeca-5,9-dien-2-yl acetate; 3,7-dimethyloctan-3-ol; and oxacyclohexadecan-2-one, wherein the perfume composition comprises less than 3% by weight of low odour ingredients having an Odour Value of less than 100, and wherein the compacted perfume composition is adapted for use as a constituent for a compacted consumer product in an amount of between 0.01 to 0.75% by weight of the compacted consumer product.

11. The process according to claim 10, further comprising the step of admixing at least one perfumery ingredient B2 belonging to none of the groups A1, A2 and B1 and having an Odour Value of 100 or more.

12. The process according to claim 10, wherein the at least three Performance Markers A1 and the at least one Performance Vehicle A2 are admixed to form a sub-composition A.

13. The process according to claim 10, wherein the at least one Performing Diluent B1 and optionally one or more other fragrance ingredients B2 are admixed to form a sub-composition B.

Description

EXAMPLE 1

(1) Table 1 provides a list of non-compacted and compacted perfume compositions. All percentages are given by weight of the total perfume composition. Under “Markers” is meant the total percentage of Performance Markers A1 in the perfume compositions. Under “Vehicles” is meant the total percentage of Performance Vehicles A2 in the perfume compositions. Under “Diluents” is meant the total percentage of Performing Diluents B1 in the perfume compositions. Under “Low Odour Ingredients” is meant the total percentage of solvents and low odour ingredients having an Odour Value of less than 100 in the perfume. Under “# Over critical Markers” is meant the total number of Performance Markers A1 being present at a concentration which is equal to or higher than their specific Critical Compaction Concentration. “NC” means not compacted; “TDC” means compacted via a top-down creation process; “BUC” means compacted via a bottom-up creation process according to the present invention.

(2) TABLE-US-00001 TABLE 1 Total % of Total % of Total % of Total % of Total % of Other Low # Over- Performance Performance Performing fragrance Odour critical Perfume Markers Vehicles Diluents ingredients Ingredients Markers A (NC) 0.04 0.36 53.2 26.9 19.5 0 B (TDC) 0.4 2.5 65.1 32.0 0 0 C (NC) 0.1 6.6 68.9 20.8 3.6 0 D (TDC) 0.5 19.8 40.5 39.2 0 1 E (NC) 0.1 6.4 54.6 33.2 5.7 0 F (BUC) 3.1 25.6 49.0 21.7 0.6 3 G (BUC) 4.8 46.6 19 29.6 0 3 H (BUC) 6.3 24.6 40.9 28.2 0 7 I (BUC) 2.7 60.4 26.6 10.3 0 3

(3) In the above table, Perfume B is a compacted version of Perfume A (having a musky woody character) in which the solvents (Low Odour Ingredients) have been replaced mostly by Performing Diluents (top-down creation process). However, the concentration of both Performance Markers and Performance Vehicles is under-critical and the compacted version has lost in bloom intensity.

(4) Perfume D is a compacted version of Perfume C (having a sweet-woody-chypre character), also obtained through a top-down process. In this case, part of the performing diluents has been replaced by more powerful Performance Vehicles. Nevertheless, the concentration of Performance Markers is still under-critical and the blooming performance of the perfume is not acceptable. Perfume D has only one Performance Marker at over-critical concentrations: Cyclogalbanate (1%).

(5) Perfume E was a perfume having strong citrus-floral character, characterized by a high level of orange essence, terpenic alcohols, hedione and woody/musky ingredients. This perfume could not be compacted using a top-down creation process without a complete loss of the citrusfloral odour direction.

(6) Conversely, Perfumes F (a strong citrus-floral perfume) and G (a fruity-floral perfume) have been obtained through a bottom-up creation process, according to the present invention. Perfume F comprised the following Performance Markers A1 at over-critical concentrations: (E)-undec-9-enal (0.1%), Rose oxide (1%) and Spirogalbanone (0.4%), and Perfume G comprised following Performance Markers A1 at over-critical concentrations: Aldehyde C 11 undecylenic (1%), Rose oxide (0.7%) and Violet nirile (0.014%). Perfumes F and G are well balanced perfumes performing extremely from both a performance and hedonic stand points.

(7) Perfumes H and I are further examples of compacted perfumes obtained by performing a bottom-up creation process in accordance with the invention: Perfume H is a strong fougère spicy oriental compacted perfume comprising following Performance Markers A1 at concentrations equal to or higher than their specific Critical Compaction Concentrations: Ambrocenide (0.05%), Damascenone (0.2%), Delta damascone (2%), Dupical (0.5%), Galbanone (0.5%), Methyl laitone (0.5%) and Shisolia (0.5%). Perfume I is a floral carnation compacted perfume comprising following Performance Markers at over-critical concentrations: Cetone V (1%), Trans-dec-4-enal (0.6%) and Rosyrane Super (0.25%).

EXAMPLE 2

(8) Performance evaluation. A series of compacted perfume compositions created according to the method and composition rules defined by the present invention were evaluated in use in a hard surface cleaner product.

(9) The base was a model base comprising 2% by weight of C14-17 secondary alkyl sulfonate (Hostapur® SAS 60, ex Clariant), 2% by weight of C13 ethoxylate (Lutensol® TO 10, ex BASF), 1% by weight of triethanolamine (ex Prolabo), 0.3% by weight of citric acid (ex Prolabo), 0.2% by weight of sodium hydroxide at 50% in dionized water (ex Prolabo) and 0.1% by weight of a mixture of NN′-dihydroxymethyl urea and 1,6-dihydroxy-2,5-dioxo-hexane (Parmetol® DF 35, ex Schulke & Mayr).

(10) The level of compacted perfume composition in the product was 0.18% by weight, whereas the level of a reference un-compacted perfume composition was 0.5% by weight. The performance of the perfume compositions in terms of smell intensity (or perfume strength) was assessed in a monadic in-home use test under domestic application conditions. The quantity of product tested was 500 ml. The product was tested three times within 10 days. The number of panellists was 85. The results are reported in Table 2.

(11) TABLE-US-00002 TABLE 2 Non compacted Compacted Compacted perfume J perfume K perfume L @ 0.5% @0.18% @0.18% Composition(*) Performance Markers A1 (%) 0.9 9.5 4.5 Performance Vehicles A2 (%) 8 12.5 27.4 Performing Diluents B1 (%) 37.0 31.0 24.8 Other fragrance ingredients (%) 47.0 46.0 40.8 Low Odour Ingredients (%) 7.1 1 2.5 # Over-critical Markers(**) 0 5 4 Performance assessment stage(***) On neat product 47% 63% 64% Bloom under dilution with water 72% 85% 79% During use 76% 86% 78% 2 hours after application 42% 52% 41% 24 hours impact (substantivity) 24% 26% 22% (*)in % by weight of the total perfume composition (**)number of Performance Markers with a concentration equal to or higher than its specific Critical Compaction Concentration, respectively (***)percentage of panellist judging that the strength of the perfume at assessment stage is at the right intensity

(12) The compacted perfume K contained the following Performance Markers A1 at concentrations equal to or above their CCC: Tridecenonitrile ((E)-tridec-2-enenitrile, 4.5%), trans-dec-4-enal (0.9%), Cassyrane (0.9%), Galbanone (0.7%), and 3,5,5-trimethylhexanal (0.7%).

(13) The compacted perfume L comprised Performance Markers A1 at over-critical concentrations equal to or above their CCC: Delta damascone (1.8%), Dupical (0.9%), trans-dec-4-enal (0.9%), Pharaone (0.14%).

EXAMPLE 3

(14) Two perfumes were tested in both conventional and compacted granulated detergent compositions. Perfume M was a non-compacted green-floral accord comprising terpene alcohols and nitriles, Iso E super, Lilial, Gardenol, Aubepine para cresol, Jasmacyclene, Peonile and Undecavertol, and Perfume N its compacted variant. The characteristics of these two perfumes are reported in Table 3. The two detergent compositions were evaluated in a monadic sequential in home consumer test. The size of the test was 150 panellists. The test conditions and the results on a scale of 7, 7 being the maximal score, are also reported in Table 3.

(15) TABLE-US-00003 TABLE 3 Non Compacted Compacted perfume M perfume N Composition(*) Performance Markers (%) 2.8 4.0 Performance Vehicles (%) 19.2 19.8 Performing Diluents (%) 43.7 40.4 Other fragrance ingredients (%) 34.3 35.8 Low odour ingredients (%) 0 0 # Over-critical Markers(**) 0 5 Detergent Conventional Compacted Detergent dosage in machine wash test (g) 150 30 Perfume dosage in detergent (%) 0.75 0.75 Consumer testing results Overall opinion of the perfume 5.7 6.0 Overall opinion of product efficiency 5.6 5.9 (*)in % by weight of the total perfume composition (**)number of Performance Markers with a concentration equal to or higher than its specific Critical Compaction Concentration, respectively.

(16) As apparent from the results of Table 3, the compacted perfume N was rated higher by the panellists at a dosage 5 times lower than that of the non compacted perfume M. This example illustrates the importance of having in a compacted perfume at least three Performance Markers being at a level higher than or equal to their Critical Compaction Concentration.

EXAMPLE 4

(17) A compacted perfume O was created comprising 5.2% by weight of Performance Markers A1, 68.6% by weight of Performance Vehicles A2 (Ethyl Maltol, Nectaryl, Petalia, Undecavertol) and 26.2% by weight of Performing Diluents B1 (Agrumex, Citrus essence, Orange essence). This perfume did not contain any additional perfume ingredient and did not contain any low odour ingredient. The compacted perfume O comprised seven Performance Markers A1 at concentrations equal to or above their CCC: Cassyrane (0.5%), Dupical (1.0%), Galbanone (1.0%), Javanol (1%), Oxane (0.75%), Rose Oxide (0.5%) and Thiogeraniol (0.1%).

EXAMPLE 5

(18) A compacted perfume P was created comprising 7.8% by weight of Performance Markers A1, 35.30% by weight of Performance Vehicles A2 (Ethyl Maltol, Nectaryl, Petalia, Undecavertol) and 23.75% by weight of Performing Diluents B1 (Agrumex, Citrus essence, Orange essence). The compacted perfume P comprised 14 Performance Markers A1. From these 14 Performance Markers, 9 had concentrations equal to or above their CCC: Aldehyde C12 MOA (0.4%), Bigaryl (0.06%), Damascone Delta (1.6%), Dupical (1.6%), Evernyl (0.8%), Galbanone (0.27.0%), Javanol (0.40%), Pyralone (0.27%), Rose Oxide (1.2%) and Violet nitrile (0.016%).